Results

Total Results: 1,010 records

Showing results for "costs".

41. Screening for Impaired Visual Acuity in Older Adults: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/caCcWa2a6jQGRyb7H8CkbU
    July 01, 2009 - Costs Given the high prevalence of vision disorders, imple- mentation of universal screening could lead … to substantial costs to the health care system. … These costs would include opportunity costs for time spent administering the visual acuity test; costs … Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration

42. AHRQ48D_TESTICULAREU.QXD (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/wsVJnJdHV9Udvm2rhJPrzZ
    February 01, 2004 - The subscription costs $60 and can be ordered through the AHRQ Publications Clearinghouse (call 1-800

43. Archived: Obesity in Adults: Screening and Management | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-screening-and-management-2012
    June 15, 2012 - The USPSTF does not consider the costs of providing a service in this assessment. … These comorbid medical conditions are associated with higher use of health care services and costs among … waist–hip ratio), address weight management in elderly adults and other subpopulations, and examine the cost-effectiveness … Some respondents asked about costs. … The USPSTF does not consider costs in its appraisal of the effectiveness of a service.

44. Archived: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening-september-2014
    September 22, 2014 - The USPSTF does not consider the costs of providing a service in this assessment. … Costs According to the CDC, STIs in the United States are associated with an annual cost of almost … In 2008, estimated direct lifetime costs (in 2010 U.S. dollars) per case of chlamydial infection were … Similarly, gonococcal infections were associated with direct costs of $79 (range, $40 to $119) in men … The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008

45. The U.S. Preventive Services Task Force: An Evidence-Based Prevention Resource for Nurse Practitioners | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/evidence-based-prevention-resource-nurse-practitioners
    April 01, 2019 - it early, there is also a problem with overuse of inappropriate services, which increases healthcare costs … overuse of several preventive services not recommended, receiving a D recommendation by the USPSTF, costs … $47-$194 million in annual direct medical costs. … Use and costs of nonrecommended tests during routine preventive health exams. 

46. Archived: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-2002
    June 13, 2002 - Studies reviewed by the USPSTF indicate that colorectal cancer screening is likely to be cost-effective … sigmoidoscopy would not detect) offsets the procedure’s additional complications, inconvenience, and costs … Initial costs of colonoscopy are higher than the costs of other tests. … Cost and Cost-Effectiveness Among 6 high-quality cost-effectiveness analyses examining only direct … costs, the average cost-effectiveness ratio values for screening adults older than 50 with each of the

47. Archived: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening-2014
    March 18, 2014 - The USPSTF does not consider the costs of providing a service in this assessment. … Costs The cost of screening varies depending on the screening instrument. … Total health, long-term, and hospice care costs for dementia in the United States were an estimated $183 … Medicare and Medicaid pay approximately 40% to 70% of these costs, representing $130 billion. … These costs do not include the estimated $202 billion in uncompensated care that informal caregivers

48. Procedure Manual Section 7. Formulation of Task Force Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-7-formulation-task-force-recommendations
    April 19, 2025 - exposure to infectious diseases, herd immunity). 7.1.3 The USPSTF does not consider the financial costs … its assessment of the balance of benefits and harms, but may provide contextual information regarding costs … for use by providers, including cost-effectiveness studies. 7.1.4 Recommendations apply only to persons

49. Procedure Manual Section 7. Formulation of Task Force Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-section-7-formulation-task-force-recommendations
    April 05, 2021 - exposure to infectious diseases, herd immunity). 7.1.3 The USPSTF does not consider the financial costs … its assessment of the balance of benefits and harms, but may provide contextual information regarding costs … for use by providers, including cost-effectiveness studies. 7.1.4 Recommendations apply only to persons

50. Screening for and Management of Obesity in Adults: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Bd9Cgr5WNueNbmfsPxUKDP
    September 01, 2012 - The USPSTF does not consider the costs of providing a service in this assessment. … These comorbid medical conditions are associated with higher use of health care services and costs among … waist–hip ratio), address weight management in elderly adults and other subpopulations, and examine the cost-effectiveness … Some respondents asked about costs. … The USPSTF does not con- sider costs in its appraisal of the effectiveness of a service.

51. Archived: Dementia in Older Adults: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/dementia-older-adults-screening-1996
    January 01, 1996 - The annual costs of treating Alzheimer's disease alone, including medical and nursing costs and lost … and inconsistent 54 but increase at higher doses. 55 The usefulness of tacrine is limited by high cost … these instruments in all older patients will be of sufficient benefit to justify the inconvenience, costs … The US economic and social costs of Alzheimer's disease revisited.

52. Procedure Manual Section 6. Methods for Arriving at a Recommendation | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-section-6-methods-arriving-recommendation
    July 06, 2017 - Harms may also be considered in the form of opportunity costs for both patients and providers. … The Task Force usually derives qualitative, rather than precise, estimates of opportunity costs. … Although opportunity costs may be considered in the determination of Task Force recommendation grades … , financial costs are not. … Yet these persons are still subject to harms (often immediate), including opportunity costs.

53. Procedure Manual Section 6. Methods for Arriving at a Recommendation | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-6-methods-arriving-recommendation
    July 06, 2017 - Harms may also be considered in the form of opportunity costs for both patients and providers. … The Task Force usually derives qualitative, rather than precise, estimates of opportunity costs. … Although opportunity costs may be considered in the determination of Task Force recommendation grades … , financial costs are not. … Yet these persons are still subject to harms (often immediate), including opportunity costs.

54. The U.S. Preventive Services Task Force: An evidence-based prevention resource for nurse practitioners (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/epbnursep.pdf
    November 01, 2007 - it early, there is also a problem with overuse of inappropriate services, which increases healthcare costs … overuse of several preventive services not recommended, receiving a D recommendation by the USPSTF, costs … $47–$194 million in annual direct medical costs. … Use and costs of nonrecommended tests during routine preventive health exams.

55. Screening for Rh (D) Incompatibility: A Brief Evidence Update (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3d2JBp6qErtFkw4JjCQ-eo
    November 01, 2004 - The subscription costs $60 and can be ordered through the AHRQ Publications Clearinghouse (call 1-800

56. Fbqmoapkebekmj7Aqmale5 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/fbQmoAPKeBekmJ7aqmALe5
    June 01, 2014 - The USPSTF does not consider the costs of providing a service in this assessment. … Costs The cost of screening varies depending on the screen- ing instrument. … Total health, long-term, and hospice care costs for dementia in the United States were an estimated $183 … Medicare and Medicaid pay approximately 40% to 70% of these costs, representing $130 billion. … These costs do not include the estimated $202 billion in uncompensated care that informal caregivers

57. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/acqA29t-vpgphFscNPEfG8
    January 01, 2020 - The USPSTF does not consider the costs of providing a ser- vice in this assessment. … the harms of screening, although the potential exists for overdiagnosis, labeling, and opportunity costs … tomography angiography (CTA) is used to confirm a di- agnosis of PAD, anxiety, labeling, and opportunity costs … sure to gadolinium or contrast dye from confirmatory MRA or CTA, anxiety, labeling, and opportunity costs … harms of screening, al- though the potential exists for overdiagnosis, labeling, and oppor- tunity costs

58. Archived: Postmenopausal Hormone Prophylaxis: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/postmenopausal-hormone-prophylaxis-preventive-medication-1996
    January 01, 1996 - Cost-effectiveness of therapy is highly sensitive to costs of medication and follow-up visits. … Effectiveness and costs of osteoporosis screening and hormone replacement therapy, vol. … I: cost-effectiveness analysis. Washington, DC: U.S. … Effectiveness and costs of osteoporosis screening and hormone replacement therapy, vol. … II: evidence on benefits, risks, and costs. Washington, DC: U.S.

59. Archived: Chlamydial Infection: Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydial-infection-screening-2001
    January 01, 2001 - There may be added cost for confirmation of positive results and testing of partners. … The USPSTF identified eight cost-effectiveness or cost-benefit analyses that examined screening in nonpregnant … However, because of inconsistencies in methodology and assumptions made in these cost analyses, the USPSTF … concludes that available evidence on cost-effectiveness is insufficient to guide specific screening … An interactive model that allows clinicians to compare the cost-effectiveness of different screening

60. Archived: Postmenopausal Osteoporosis: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/postmenopausal-osteoporosis-screening-1996
    January 01, 1996 - osteoporosis-related fractures in the U.S. has been estimated to be over $8 billion in direct and indirect costs … are of limited value in estimating bone mass. 19 The other techniques vary in their availability, cost … may be useful in the clinical setting. 24 Reproducibility of SPA is similar to DPA and DXA, but the cost … Screening times vary from 5-15 minutes for SPA and DXA to 20-45 minutes for QCT and DPA. 24 Average costs … estimated to be $75 with SPA, $75-100 with DXA, $100-150 with DPA, and $100-200 with QCT. 23 , 24 The costs